Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
339
datasets available to search
ShareScore release 0.9.0
Dataset results
339 results for “CML”
A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML
ClinicalTrials.gov study NCT02896842. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL
ClinicalTrials.gov study NCT00384228. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
ClinicalTrials.gov study NCT04948333. IPD Sharing: YES. Countries: 16. Publications: 0.
A Study for PRO of CML in Real Word
ClinicalTrials.gov study NCT05092048. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)
ClinicalTrials.gov study NCT02421926. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Iclusig PMS in CML or Ph+ALL Patients
ClinicalTrials.gov study NCT03709017. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy
ClinicalTrials.gov study NCT00297570. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Withdrawal or Reduction TKIs in CML-CP
ClinicalTrials.gov study NCT04143087. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
ClinicalTrials.gov study NCT01690065. IPD Sharing: Not stated. Countries: 1. Publications: 32.
Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients
ClinicalTrials.gov study NCT02201459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML
ClinicalTrials.gov study NCT00416884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects
ClinicalTrials.gov study NCT00529763. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization
ClinicalTrials.gov study NCT02975115. IPD Sharing: NO. Countries: 0. Publications: 1.
Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
ClinicalTrials.gov study NCT01660906. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML
ClinicalTrials.gov study NCT00702403. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)
ClinicalTrials.gov study NCT00500006. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT04795427. IPD Sharing: YES. Countries: 1. Publications: 0.
Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI
ClinicalTrials.gov study NCT00363649. IPD Sharing: NO. Countries: 1. Publications: 0.
Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy
ClinicalTrials.gov study NCT02353728. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation
ClinicalTrials.gov study NCT06427811. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.